Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Journal of Gastrointestinal Cancer|April 15, 2022
Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical TrialMahdi Aghili, Nima Mousavi Darzikolaee, Mohammad Babaei, et al.Journal of Contemporary Brachytherapy|May 24, 2018
High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution studyBita Kalaghchi, Ebrahim Esmati, Reza Ghalehtaki, et al.Journal of Medical Radiation Sciences|August 20, 2021
Low-dose whole-lung irradiation in severe COVID-19 pneumonia: a controlled clinical trialNima Mousavi Darzikolaee, Kasra Kolahdouzan, Hamidreza Abtahi, et al.Journal of Gastrointestinal Cancer|November 8, 2018
Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in IranFarshid Farhan, Reza Ghalehtaki, Shiva Mahdavi-Seresht, et al.Journal of Contemporary Brachytherapy|December 25, 2024
Surface mold brachytherapy for head and neck non-melanoma skin cancer - local control rates and survival: A retrospective analysisEbrahim Esmati, Romina Abyaneh, Ramin Jaberi, et al.Clinical and Translational Radiation Oncology|April 20, 2026
Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancerEbrahim Esmati, Reza Nazari, Ali Aqamolaei, et al.Cancer Reports (Hoboken, N.J.)|August 25, 2025
Human Epidermal Growth Factor Receptor 2 [HER-2/neu] Amplification and Microsatellite Stable Status in Gastric and Gastroesophageal Adenocarcinoma: Assessing Frequency and Prognostic Implications at the Cancer Institute of IranSamaneh Salarvand, Abbas Mohammadi, Reza Shahsiah, et al.Radiation Oncology Journal|January 3, 2025
Outcomes of neoadjuvant chemoradiotherapy in T4 rectal cancer patients: a real-world single institution experienceReza Ghalehtaki, Kasra Kolahdouzan, Guglielmo Niccolò Piozzi, et al.Radiation Oncology (London, England)|December 3, 2024
Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysisAmirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, et al.International Journal of Colorectal Disease|May 4, 2026
Complete pathologic response surrogacy for survival and its predictors in locally advanced rectal cancer: a retrospective cohort studyReza Ghalehtaki, Romina Abyaneh, Samaneh Salarvand, et al.Pageof 8